Literature DB >> 8399335

Purification and characterization of a phospholipase A2 from human ileal mucosa.

T Minami1, H Tojo, Y Shinomura, Y Matsuzawa, M Okamoto.   

Abstract

We purified a phospholipase A2 (PLA2) from human ileal mucosa to homogeneity. Its NH2-terminal amino acid sequence, amino acid composition, molecular weight, and elution behavior on reverse phase high-performance liquid chromatography were identical to those of human group II PLA2 purified from synovial fluid or spleen. The ileal PLA2 preferred anionic phosphatidylglycerol as substrate. On immunoblot analysis, human ileal mucosa gave more intense immunoreactivity with anti-human synovial fluid PLA2 antibody, at the same position as the purified enzyme, than the cecal mucosa. Northern blot analysis also showed that the level of group II PLA2 mRNA in the ileal mucosa was greater than that in the cecal mucosa. The enzyme was rather uniformly distributed over the colonic mucosa, from cecum to sigmoid colon. These results indicate that the ileal mucosa contains group II PLA2, and that its expression in the ileal mucosa was higher than that in the colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399335

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears.

Authors:  X D Qu; R I Lehrer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Group II phospholipase A2 is not a major modifier of colonic adenomatous polyps in humans.

Authors:  T Minami; S Kanayama; H Tojo; I Akedo; Y Matsuzawa
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

3.  Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.

Authors:  A P Tarver; D P Clark; G Diamond; J P Russell; H Erdjument-Bromage; P Tempst; K S Cohen; D E Jones; R W Sweeney; M Wines; S Hwang; C L Bevins
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Broad-spectrum antimicrobial activity of human intestinal defensin 5.

Authors:  E M Porter; E van Dam; E V Valore; T Ganz
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Secretion of type II phospholipase A2 and cryptdin by rat small intestinal Paneth cells.

Authors:  X D Qu; K C Lloyd; J H Walsh; R I Lehrer
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.

Authors:  I Lilja; K Smedh; G Olaison; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

7.  The effect of hypoxia on permeability and bacterial translocation in Caco-2 adult and I-407 fetal enterocyte cell culture models.

Authors:  Y Tazuke; R A Drongowski; D H Teitelbaum; A G Coran
Journal:  Pediatr Surg Int       Date:  2003-05-06       Impact factor: 1.827

8.  Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; Y Matsuzawa; M Okamoto
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

9.  Bactericidal properties of murine intestinal phospholipase A2.

Authors:  S S Harwig; L Tan; X D Qu; Y Cho; P B Eisenhauer; R I Lehrer
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.